KIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NK cell subsets in SIV-infected Mamu-A*01-Negative rhesus macaques

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 5305-5310

  Hellmann, Ina ^a   Letvin, Norman L ^a   Schmitz, Jörn E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VARIABILITY; KIR2DL4 GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PRESERVATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T CELL DEPLETION; VIRUS PATHOGENESIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MACACA MULATTA; RECEPTORS, KIR2DL4; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84876329246     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02949-12     Document Type: Article

References (40)

1. Vilches C, Parham P. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20:217-251.
2. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
3. Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, Kirk GD, O'Brien SJ, Trowsdale J, Carrington M. 2006. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2:e79. doi:10.1371/journal.ppat.0020079.
4. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, Lifson JD, Allen TM, Carrington M, Altfeld M. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204:3027-3036.
5. Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR. 2007. Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3:e43. doi:10.1371/journal.ppat.0030043.
6. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740.
7. Carrington M, Martin MP, van Bergen J. 2008. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16:620-627.
8. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, Miller JS, Carrington M, Altfeld M. 2009. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83:6798-6805.
9. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM, Martinson JJ, Jamieson BD, Bream JH, Martin MP, Borrow P, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Carrington M, Goldstein DB, Alter G. 2011. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 9:e1001208. doi:10.1371/journal.pbio.1001208.
10. 9:e1001208. doi:10.1371/journal.pbio.1001208. 10. Carrington M, Alter G. 2012. Innate immune control of HIV. Cold Spring Harbor Perspect. Med. 2:a007070. doi:10.1101/cshperspect .a007070.
11. Hellmann I, Lim SY, Gelman RS, Letvin NL. 2011. Association of activating KIR copy number variation ofNKcells with containment of SIV replication in rhesus monkeys. PLoS Pathog. 7:e1002436. doi:10.1371/journal.ppat.1002436.
12. Hershberger KL, Shyam R, Miura A, Letvin NL. 2001. Diversity of the killer cell Ig-like receptors of rhesus monkeys. J. Immunol. 166:4380-4390.
13. Yusa S, Catina TL, Campbell KS. 2002. SHP-1-and phosphotyrosineindependent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J. Immunol. 168:5047-5057.
14. Faure M, Long EO. 2002. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168:6208-6214.
15. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. 2003. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J. Immunol. 171:3415-3425.
16. Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE. 2009. Evidence for balancing selection acting on KIR2DL4 genotypes in rhesus macaques of Indian origin. Immunogenetics 61:503-512.
17. Fry AM, Lanier LL, Weiss A. 1996. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 184:295-300.
18. Bruhns P, Marchetti P, Fridman WH, Vivier E, Daeron M. 1999. Differential roles of N-and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J. Immunol. 162:3168-3175.
19. Long EO. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:875-904.
20. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
21. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97:3146-3151.
22. Rajagopalan S, Fu J, Long EO. 2001. Cutting edge: induction of IFNgamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167:1877-1881.
23. Kikuchi-Maki A, Catina TL, Campbell KS. 2005. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J. Immunol. 174:3859-3863.
24. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4:e9. doi:10.1371/journal .pbio.0040009.
25. Degenhardt JD, de Candia P, Chabot A, Schwartz S, Henderson L, Ling B, Hunter M, Jiang Z, Palermo RE, Katze M, Eichler EE, Ventura M, Rogers J, Marx P, Gilad Y, Bustamante CD. 2009. Copy number variation of CCL3-like genes affects rate of progression to simian-AIDS in rhesus macaques (Macaca mulatta). PLoS Genet. 5:e1000346. doi:10.1371/journal.pgen.1000346.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
27. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
28. Bostik P, Kobkitjaroen J, Tang W, Villinger F, Pereira LE, Little DM, Stephenson ST, Bouzyk M, Ansari AA. 2009. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J. Immunol. 182:3638-3649.
29. Chaichompoo P, Bostik P, Stephenson S, Udompunturuk S, Kobkitjaroen J, Pattanapanyasat K, Ansari AA. 2010. Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques. Cell. Immunol. 263:176-187.
30. Webster RL, Johnson RP. 2005. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115:206-214.
31. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP. 2010. CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115:4439-4446.
32. Williams F, Maxwell LD, Halfpenny IA, Meenagh A, Sleator C, Curran MD, Middleton D. 2003. Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. Hum. Immunol. 64:729-732.
33. Traherne JA, Martin M, Ward R, Ohashi M, Pellett F, Gladman D, Middleton D, Carrington M, Trowsdale J. 2010. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum. Mol. Genet. 19:737-751.
34. Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT. 2005. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 6:683-690.
35. Goodridge JP, Witt CS, Christiansen FT, Warren HS. 2003. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J. Immunol. 171:1768-1774.
36. Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE. 2010. The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics 62:295-306.
37. Witt CS, Martin A, Christiansen FT. 2000. Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens 56:248-257.
38. Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, Nkengasong JN, Kestens L. 2011. Low CD4+T cell counts among African HIV-1 infected subjects with groupBKIR haplotypes in the absence of specific inhibitory KIR ligands. PLoS One 6:e17043. doi:10.1371/journal.pone.0017043.
39. O'Connell KA, Han Y, Williams TM, Siliciano RF, Blankson JN. 2009. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J. Virol. 83:5028-5034.
40. Hosmalin A, Lebon P. 2006. Type I interferon production in HIVinfected patients. J. Leukoc. Biol. 80:984-993.